Authors

• Alexander Melamed (ORCID: https://orcid.org/0000-0002-0654-0863)
• Luc R.C.W. van Lonkhuijzen (ORCID: https://orcid.org/0000-0001-6905-2704)
• Ying Yuan (ORCID: https://orcid.org/0000-0003-3163-480X)
• Jose Alejandro Rauh‐Hain (ORCID: https://orcid.org/0000-0001-9985-5954)
• Taymaa May (ORCID: https://orcid.org/0000-0002-9242-2969)
• Pedro T. Ramírez (ORCID: https://orcid.org/0000-0002-6370-8052)
• Maria D. Iniesta (ORCID: https://orcid.org/0000-0001-7306-5081)
• Chad M. Michener (ORCID: https://orcid.org/0000-0001-5170-6626)
• Abdulrahman Sinno (ORCID: https://orcid.org/0000-0001-5559-0704)
• René Pareja (ORCID: https://orcid.org/0000-0003-0093-0438)
• Pierandrea De Iaco (ORCID: https://orcid.org/0000-0002-8841-6531)
• Neil S. Horowitz (ORCID: https://orcid.org/0000-0002-4854-0642)
• Leah McNally (ORCID: https://orcid.org/0000-0001-7567-0162)
• Anna Fagotti

Institutions

• Houston Methodist (US)
• Cleveland Clinic (US)
• The University of Texas MD Anderson Cancer Center (US)
• Harvard University (US)
• University of Miami (US)
• Duke University (US)
• University of Toronto (CA)
• Agostino Gemelli University Polyclinic (IT)
• Princess Margaret Cancer Centre (CA)
• Massachusetts General Hospital (US)
• Methodist Hospital (US)
• Dana-Farber Cancer Institute (US)
• Instituto Nacional de Cancerología (CO)
• Azienda USL di Bologna (IT)

Publication Details

Journal

JAMA Network Open

Published

2024-11-21

DOI

https://doi.org/10.1001/jamanetworkopen.2024.46325

Citations

16

Primary Topic

Ovarian cancer diagnosis and treatment

Type

article

Field-Weighted Citation Impact

8.59

Funders

• U.S. Department of Defense
• AstraZeneca
• GlaxoSmithKline
• Myriad Genetics
• Fondazione Internazionale Menarini
• National Institutes of Health
• National Cancer Institute